Characteristics of patients with Vogt Koyana Harada disease of Hospital de Clinicas Rheumatology Department
PDF (Spanish)
HTML (Spanish)

Keywords

Granulomatous panuveitis
Vogt koyanagi Harada disease

How to Cite

1.
Losanto J, Riquelme S, Román L, Yinde Y, Colman N. Characteristics of patients with Vogt Koyana Harada disease of Hospital de Clinicas Rheumatology Department. Rev. parag. reumatol. [Internet]. 2016 Dec. 30 [cited 2026 Jan. 16];2(2):72-5. Available from: https://revista.spr.org.py/index.php/spr/article/view/40

Abstract

Introduction: Vogt-Koyanagi-Harada´s disease (VKHD) is a bilateral, diffuse and chronic granulomatous panuveitis characterized by serous retinal detachment. This disease is often associated with neurological, auditory and dermatological disorders. Objetive: To describe the characteristics of patients with VKHD in our rheumatology service. Methods: Retrospective study based on the review of medical records of patients with a diagnosis of VKH who are being followed by the Department of Rheumatology of Hospital de Clínicas of FCM – UNA from 2000 until 2015. Results: We reviewed 3727 clinical records of which 8 patients with VKH were identified. Mean age at diagnosis was 44.6 ± 8.8 years. All of these patients were referred to the clinic for decreased visual acuity. Six patients (75 %) had serous retinal detachment. Dermatologic symptoms were found in 2/8 (25 %) patients and auditory symptoms were present in 2/8 (25 %) patients as well. General symptoms such as malaise and fever were present in 1/8 (12.5 %) patient. Neurological alterations were observed in 3/8 (37.5 %) patients. All patients received high doses of systemic glucocorticoids and 2/8 (25 %) of the patients also received NSAIDs. Of the total number of patients, 3/8 (37.5 %) received cyclophosphamide, 5/8 (62.5 %) azathioprine and 1/8 (12.5%) methotrexate. Some patients received more than one immunosuppressant. The final visual acuity improved in 75% (6/8) of the cases, but 2/8 (25 %) of them had poor visual outcome. Ocular complications such as cataracts were seen in 2/8 (25 %) of patients. Synechiae and glaucoma were seen in an equal amount (25 %). In-band keratitis was found in 1/8 (12.5 %) patient. No patient required vitrectomy or developed ocular hypotension. Conclusion: All patients required immunosuppressants and most of the patients had a favorable outcome. The clinical manifestations and the female predominance coincide with the current literature. Our cases reaffirm the fact that with early and aggressive management, the prognosis of this disease is favorable.
PDF (Spanish)
HTML (Spanish)

References

(1) Ramírez Rosales A, Gongora Rivera F, Garcia Pompemayer M, Rodriguez-Robles L, Velarde Magaña G. Enfermedad de Vogt Koyanagi Harada. Rev Mex Neuroci. 2012;13(5):275-280.

(2) Triana Casado I, Molina Cisneros C. Probable síndrome de Vogt Koyanagi Harada. Informe de un caso. Rev. Mex. Oftalmol. 2011;3(85):156-160.

(3) Sabat P, Velásquez V. Úvea y Enfermedades Sistémicas. Rev. Med. Clin. Condes. 2010; 21(6): 921-929.

(4) Hernández Bell L, Castro Navarro V, Palomares Fort P, Hernandez Garfella M, Beltran Catalan E, Calvo Catala J et al. Síndrome de Vogt Koyanagi Harada. A propósito de un caso Rev. Sociedad Val. Reuma. 2015;6(1):12-14.

(5) Tapia G, Benavides R, Tapia A. Enfermedad de Vogt – Koyanagi Harada. Reporte de un caso y revisión de la literatura. Rev Med de Costa Rica y Centroamérica. 2005;571:71-78.

(6) Riveros Frutos A, Romera P, Holgado Perez S, Anglada Escalona J, Martinez Morillo M, Tejera Segura B. Enfermedad de Vogt Koyanagi Harada. Semin Fund Esp Reumatol. 2012;13(4):142-146.

(7) Lavezzo MM, Sakata VM, Morita C, Rodriguez EE, Abdallah SF, da Silva FT,et al. Vogt-Koyanagi-Harada disease: review of a rare auto inmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016,24;11:29. doi: 10.1186/s13023-016-0412-4.

(8) Bordaberry MF. Vogt Koyanagi Harada disease. Diagnosis and treatments update. 2010; 21(6):430-435.

(9) Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001 May;131(5):647-52.

(10) Murthy SI, Moreker MR, Sangwan VS, Khanna RC , Tejwani S. The spectrum of Vogt Koyanagi Harada disease in South India. International Ophthalmology. 2007;27(2):131-136.

(11) Chee SP, Jap A, Bacsal K. Spectrum of Vogt Koyanagi Harada disease in Singapore. International Ophthalmology. 2007;27(2):137-142.

(12) Sukavatcharin S, Tsai JH, Rao NA. Vogt Koyanagi Harada disease in Hispanic patients. International Ophthalmology. 2007;27(2):143-148.

Downloads

Download data is not yet available.